Protagonist Therapeutics Inc (PTGX)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 252,843 | -93,652 | -131,373 | -125,845 | -64,516 |
| Total assets | US$ in thousands | 744,725 | 357,951 | 247,928 | 347,695 | 324,468 |
| Operating ROA | 33.95% | -26.16% | -52.99% | -36.19% | -19.88% |
December 31, 2024 calculation
Operating ROA = Operating income ÷ Total assets
= $252,843K ÷ $744,725K
= 33.95%
Protagonist Therapeutics Inc's operating return on assets (operating ROA) has exhibited fluctuating trends over the past five years. As of December 31, 2020, the operating ROA was at -19.88%, indicating that the company generated a negative return relative to its assets. This negative trend worsened by December 31, 2021, with the operating ROA sinking to -36.19%.
The performance continued to deteriorate into the following year, where the operating ROA reached its lowest point at -52.99% as of December 31, 2022. This significant decline suggests that Protagonist Therapeutics Inc faced challenges in utilizing its assets effectively to generate operating income during this period.
However, by December 31, 2023, there was a partial recovery in the operating ROA, although it remained negative at -26.16%. The most recent data as of December 31, 2024, shows a notable improvement with the operating ROA turning positive at 33.95%. This positive shift indicates that the company has started to generate operating profits relative to its assets.
Overall, the fluctuating trajectory of Protagonist Therapeutics Inc's operating ROA suggests varying levels of asset utilization efficiency and operating performance over the analyzed period. Further analysis and context regarding the company's strategic initiatives and market conditions would provide a deeper understanding of the factors influencing these metrics.
Peer comparison
Dec 31, 2024